Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.

Molecular diagnosis & therapy - 1 Dec 2015

Weiderpass Elisabete, Tyczynski Jerzy E

Abstract excerpt

Ovarian cancer survival rates have improved only slightly in recent decades; however, treatment of this disease is expected to undergo rapid change as strategies incorporating molecular-targeted therapies enter clinical practice. Carriers of deleterious mutations (defined as a harmful mutation) in either the BRCA1 or BRCA2 gene (BRCAm) have a significantly increased risk of developing ovarian cancer. Epidemiology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Early Diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Mass Screening

Share to Molecular Targeted Therapy

Share to Neoplasms, Cystic, Mucinous, and Serous

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 26476542
DOI: 10.1007/s40291-015-0168-x

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.PMID 26476542Read ↗

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.Semantic proximity Read ↗

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.Semantic proximity Read ↗

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionSemantic proximity Read ↗

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.Semantic proximity Read ↗

Assessing Frequency and Clinical Outcomes of BRCA Mutated Ovarian Cancer in Saudi WomenSemantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.Semantic proximity Read ↗

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.Semantic proximity Read ↗

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.Semantic proximity Read ↗

Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.